Delivery of Inhaled Drugs for Infants and Small Children: A Commentary on Present and Future Needs

Clinical Therapeutics

Volumn 34, Issue 11, 2012, Pages

  Fink, James B ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

Author keywords

Aerosol; Devices; Dosage; Dosing; In vitro in vivo; Infants; Inhaler; Nebulizers; Neonate; Pediatric

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DIURETIC AGENT; DORNASE ALFA; SALBUTAMOL;

AEROSOL; AIRWAY; ARTICLE; ASTHMA; BREATHING PATTERN; BREATHING RATE; CHILD CARE; CHRONIC LUNG DISEASE; CLINICAL TRIAL (TOPIC); CYSTIC FIBROSIS; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG INDUSTRY; DRUG MEGADOSE; DRUG SAFETY; EXPIRATORY FLOW; HEART RATE; HOSPITALIZATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFANT; INHALATIONAL DRUG ADMINISTRATION; LUNG CAPACITY; LUNG DISEASE; METERED DOSE INHALER; NASOGASTRIC TUBE; NEBULIZER; OFF LABEL DRUG USE; OXYGEN NASAL CANNULA; PHARMACIST; PRESCRIPTION; SIDE EFFECT; THINKING; TREATMENT DURATION; TREMOR;

ADMINISTRATION, INHALATION; ADOLESCENT; AEROSOLS; AGE FACTORS; BODY SIZE; CHEMISTRY, PHARMACEUTICAL; CHILD; CHILD, PRESCHOOL; DRUG DOSAGE CALCULATIONS; EQUIPMENT DESIGN; HUMANS; INFANT; INFANT, NEWBORN; MODELS, BIOLOGICAL; NEBULIZERS AND VAPORIZERS; OFF-LABEL USE; PHARMACEUTICAL PREPARATIONS; RISK FACTORS; TECHNOLOGY, PHARMACEUTICAL;

EID: 84869038523     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2012.10.004     Document Type: Article

References (43)

1. Fink J.B., Rubin B.K. Aerosol and medication administration. Perinatal and Pediatric Respiratory Care 2003, Elsevier Science, St. Louis, Mo. M.P. Czerviske, S.L. Barnhart (Eds.).
2. Ahrens R.C. The role of the MDI and DPI in pediatric patients: "Children are not just miniature adults.". Respir Care 2005, 50:1323-1328.
3. Everard M.L. Inhalation therapy for infants. Adv Drug Deliv Rev 2003, 55:869-878.
4. Devadason S.G., Le Souef P.N. Age-associated factors influencing the efficacy of various forms of aerosol therapy. J Aerosol Med 2002, 15:343-345.
5. Ari A., Fink J. Guidelines for aerosol devices in infants, children and adults: which to choose, why and how to achieve effective aerosol therapy?. Expert Rev Respir Med 2011, 5:561-572.
6. Fink J.B., Rubin B.K. Problems with inhaler use: a call for improved clinician and patient education. Respir Care 2005, 50:1360-1374.
7. Dolovich M.B., Ahrens R.C., Hess D.R., et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 2005, 127:335-371.
8. Lowenthal D., Kattan M. Facemasks versus mouthpieces for aerosol treatment of asthmatic children. Pediatr Pulmonol 1992, 14:192-196.
9. Mellon M., Leflein J., Walton-Bowen K., et al. Comparable efficacy of administration with facemask or mouthpiece of nebulized budesonide inhalation suspension for infants and young children with persistent asthma. Am J Respir Crit Care Med 2000, 162:593-598.
10. Ari A., Fink J. Effective bronchodilator resuscitation of children in the emergency department: device or interface?. Editorial. Respir Care 2011, 56:882-885.
11. Geller D.E. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler. Respir Care 2005, 50:1313-1321.
12. Ari A., Hess D., Myers T.R., Rau J.L. A Guide to Aerosol Delivery Devices for Respiratory Therapists 2009, American Association for Respiratory Care, Dallas, Tex.
13. Dolovich M.B., Dhand R. Aerosol drug delivery: developments in device design and clinical use. Lancet 2010, 377:1032-1045.
14. Fink J.B., Ari A. Aerosol drug therapy. Egan's Fundamentals of Respiratory Care 2012, 844-886. Mosby Elsevier, St. Louis, Mo. R.M. Kacmarek, J.K. Stoller, L. Heuert (Eds.).
15. Rubin B.K., Fink J.B. Optimizing aerosol delivery by pressurized metered-dose inhalers. Respir Care 2005, 50:1191-1200.
16. Rubin B.K., Fink J.B. The delivery of inhaled medication to the young child. Pediatr Clin North Am 2003, 50:717-731.
17. Fink J.B. Inhalers in asthma management: is demonstration the key to compliance?. Respir Care 2005, 50:598-600.
18. Ari A., Fink J.B. Off-label use of nebulized medications in respiratory care. Treatment Strategies - Respiratory 2012, 3:44. (in press).
19. Smyth A.R., Barbato A., Beydon N., et al. Respiratory medicines for children: current evidence, unlicensed use and research priorities. Eur Respir J 2010, 35:247-265.
20. Lass J., Kaar R., Jogi K., et al. Drug utilisation pattern and off-label use of medicines in Estonian neonatal units. Eur J Clin Pharmacol 2011, 67:1263-1271.
21. Tobin J.R. Use of pharmaceuticals 'off-label' in the neonate. Best Pract Res Clin Anaesthesiol 2010, 24:451-460.
22. Dessi A., Salemi C., Fanos V., Cuzzolin L. Drug treatments in a neonatal setting: focus on the off-label use in the first month of life. Pharm World Sci 2010, 32:120-124.
23. Lindell-Osuagwu L., Korhonen M.J., Saano S., et al. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature. J Clin Pharm Ther 2009, 34:277-287.
24. Dell'Aera M., Gasbarro A.R., Padovano M., et al. Unlicensed and off-label use of medicines at a neonatology clinic in Italy. Pharm World Sci 2007, 29:361-367.
25. Pandolfini C., Bonati M. A literature review on off-label drug use in children. Eur J Pediatr 2005, 164:552-558.
26. Conroy S., Choonara I., Impicciatore P., et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. BMJ 2000, 320:79-82.
27. Mukattash T.L., Wazaify M., Khuri-Boulos N., et al. Perceptions and attitudes of Jordanian paediatricians towards off-label paediatric prescribing. Int J Clin Pharm 2011, 33:964-973.
28. Jong G.W., Eland I.A., Sturkenboom M.C., et al. Determinants for drug prescribing to children below the minimum licensed age. Eur J Clin Pharmacol 2003, 58:701-705.
29. McIntyre J., Conroy S., Avery A., et al. Unlicensed and off label prescribing of drugs in general practice. Arch Dis Child 2000, 83:498-501.
30. Grover C., Armour C., Asperen P.P., et al. Medication use in children with asthma: not a child size problem. J Asthma 2011, 48:1085-1103.
31. McCowan C., Hoskins G., Neville R.G. Clinical symptoms and 'off-label' prescribing in children with asthma. Br J Gen Pract 2007, 57:220-222.
32. Ng G.Y., Ohlsson A. Cromolyn sodium for the prevention of chronic lung disease in preterm infants. Cochrane Database Syst Rev 2008, (2). CD003059.
33. Brion L.P., Primhak R.A., Yong W. Aerosolized diuretics for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev 2010, (3). CD001694.
34. Ng G.Y., da S., Ohlsson A. Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants. Cochrane Database Syst Rev 2008, (3). CD003214.
35. National Asthma Education and Prevention Program. Expert Panel III: Guidelines for the Diagnosis and Management of Asthma 2007, Bethesda, Md.
36. Wildhaber J.H., Janssens H.M., Pierart F., et al. High percentage lung delivery in children from detergent-treated spacers. Pediatr Pulmonol 2000, 29:389-393.
37. Dolovich M.B. Assessing nebulizer performance. Respir Care 2002, 47:1290-1301.
38. Nikander K., Berg E., Smaldone G.C. Jet nebulizers versus pressurized metered dose inhalers with valved holding chambers: effects of the facemask on aerosol delivery. J Aerosol Med 2007, 20(Suppl 1):S46-S58.
39. Janssens H.M., Tiddens H.A. Facemasks and aerosol delivery by metered dose inhaler-valved holding chamber in young children: a tight seal makes the difference. J Aerosol Med 2007, 20(Suppl 1):S59-S63. discussion S63-S65.
40. Janssen J.M., van der Wiel E.C., Verbraak A.F., et al. Aerosol therapy and the fighting toddler: is administration during sleep an alternative?. J Aerosol Med 2003, 16:395-400. 4.
41. Murakami G., Igarashi T., Adachi Y., et al. Measurement of bronchial hyperactivity in infants and preschool children using a new method. Ann Allergy 1990, 64:383-387.
42. Erzinger S., Schueepp K.G., Brooks-Wildhaber J., et al. Facemasks and aerosol delivery in vivo. J Aerosol Med 2007, 20(Suppl1):S78-S83. discussion S83-S84.
43. Esposito-Festen J.E., Ates B., van Vliet F.H., et al. Effect of a facemask leak on aerosol delivery from a pMDI-spacer system. J Aerosol Med 2004, 17:1-6.